157 related articles for article (PubMed ID: 37621413)
1. Treatment of autosomal dominant retinitis pigmentosa caused by RHO-P23H mutation with high-fidelity Cas13X in mice.
Yan Z; Yao Y; Li L; Cai L; Zhang H; Zhang S; Xiao Q; Wang X; Zuo E; Xu C; Wu J; Yang H
Mol Ther Nucleic Acids; 2023 Sep; 33():750-761. PubMed ID: 37621413
[TBL] [Abstract][Full Text] [Related]
2. Retinal degeneration in humanized mice expressing mutant rhodopsin under the control of the endogenous murine promoter.
Liu X; Jia R; Meng X; Li Y; Yang L
Exp Eye Res; 2022 Feb; 215():108893. PubMed ID: 34919893
[TBL] [Abstract][Full Text] [Related]
3. Cas9/sgRNA selective targeting of the P23H Rhodopsin mutant allele for treating retinitis pigmentosa by intravitreal AAV9.PHP.B-based delivery.
Giannelli SG; Luoni M; Castoldi V; Massimino L; Cabassi T; Angeloni D; Demontis GC; Leocani L; Andreazzoli M; Broccoli V
Hum Mol Genet; 2018 Mar; 27(5):761-779. PubMed ID: 29281027
[TBL] [Abstract][Full Text] [Related]
4. Effect of AAV-Mediated Rhodopsin Gene Augmentation on Retinal Degeneration Caused by the Dominant P23H Rhodopsin Mutation in a Knock-In Murine Model.
Orlans HO; Barnard AR; Patrício MI; McClements ME; MacLaren RE
Hum Gene Ther; 2020 Jul; 31(13-14):730-742. PubMed ID: 32394751
[TBL] [Abstract][Full Text] [Related]
5. Genomic form of rhodopsin DNA nanoparticles rescued autosomal dominant Retinitis pigmentosa in the P23H knock-in mouse model.
Mitra RN; Zheng M; Weiss ER; Han Z
Biomaterials; 2018 Mar; 157():26-39. PubMed ID: 29232624
[TBL] [Abstract][Full Text] [Related]
6. CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa.
Wu WH; Tsai YT; Huang IW; Cheng CH; Hsu CW; Cui X; Ryu J; Quinn PMJ; Caruso SM; Lin CS; Tsang SH
Mol Ther; 2022 Apr; 30(4):1407-1420. PubMed ID: 35150888
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/SaCas9-based gene editing rescues photoreceptor degeneration throughout a rhodopsin-associated autosomal dominant retinitis pigmentosa mouse model.
Du W; Li J; Tang X; Yu W; Zhao M
Exp Biol Med (Maywood); 2023 Oct; 248(20):1818-1828. PubMed ID: 37837380
[TBL] [Abstract][Full Text] [Related]
8. Subcellular localization of mutant P23H rhodopsin in an RFP fusion knock-in mouse model of retinitis pigmentosa.
Robichaux MA; Nguyen V; Chan F; Kailasam L; He F; Wilson JH; Wensel TG
Dis Model Mech; 2022 May; 15(5):. PubMed ID: 35275162
[TBL] [Abstract][Full Text] [Related]
9. Long-term rescue of retinal structure and function by rhodopsin RNA replacement with a single adeno-associated viral vector in P23H RHO transgenic mice.
Mao H; Gorbatyuk MS; Rossmiller B; Hauswirth WW; Lewin AS
Hum Gene Ther; 2012 Apr; 23(4):356-66. PubMed ID: 22289036
[TBL] [Abstract][Full Text] [Related]
10. Knockout and Replacement Gene Surgery to Treat Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa.
Sun X; Liang C; Chen Y; Cui T; Han J; Dai M; Zhang Y; Zhou Q; Li W
Hum Gene Ther; 2024 Mar; 35(5-6):151-162. PubMed ID: 38368562
[TBL] [Abstract][Full Text] [Related]
11. Allele-specific gene-editing approach for vision loss restoration in
Liu X; Qiao J; Jia R; Zhang F; Meng X; Li Y; Yang L
Elife; 2023 Jun; 12():. PubMed ID: 37272616
[TBL] [Abstract][Full Text] [Related]
12. AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa.
Mao H; James T; Schwein A; Shabashvili AE; Hauswirth WW; Gorbatyuk MS; Lewin AS
Hum Gene Ther; 2011 May; 22(5):567-75. PubMed ID: 21126223
[TBL] [Abstract][Full Text] [Related]
13. In vivo Editing of the Human Mutant Rhodopsin Gene by Electroporation of Plasmid-based CRISPR/Cas9 in the Mouse Retina.
Latella MC; Di Salvo MT; Cocchiarella F; Benati D; Grisendi G; Comitato A; Marigo V; Recchia A
Mol Ther Nucleic Acids; 2016 Nov; 5(11):e389. PubMed ID: 27874856
[TBL] [Abstract][Full Text] [Related]
14. Allele-Specific CRISPR-Cas9 Genome Editing of the Single-Base P23H Mutation for Rhodopsin-Associated Dominant Retinitis Pigmentosa.
Li P; Kleinstiver BP; Leon MY; Prew MS; Navarro-Gomez D; Greenwald SH; Pierce EA; Joung JK; Liu Q
CRISPR J; 2018 Feb; 1(1):55-64. PubMed ID: 31021187
[TBL] [Abstract][Full Text] [Related]
15. CRISPR DNA Base Editing Strategies for Treating Retinitis Pigmentosa Caused by Mutations in
Kaukonen M; McClements ME; MacLaren RE
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893064
[TBL] [Abstract][Full Text] [Related]
16. Flavonoids improve the stability and function of P23H rhodopsin slowing down the progression of retinitis pigmentosa in mice.
Ortega JT; Parmar T; Carmena-Bargueño M; Pérez-Sánchez H; Jastrzebska B
J Neurosci Res; 2022 Apr; 100(4):1063-1083. PubMed ID: 35165923
[TBL] [Abstract][Full Text] [Related]
17. AAV-CRISPR/Cas9 Gene Editing Preserves Long-Term Vision in the P23H Rat Model of Autosomal Dominant Retinitis Pigmentosa.
Shahin S; Xu H; Lu B; Mercado A; Jones MK; Bakondi B; Wang S
Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456659
[TBL] [Abstract][Full Text] [Related]
18. P23H opsin knock-in mice reveal a novel step in retinal rod disc morphogenesis.
Sakami S; Kolesnikov AV; Kefalov VJ; Palczewski K
Hum Mol Genet; 2014 Apr; 23(7):1723-41. PubMed ID: 24214395
[TBL] [Abstract][Full Text] [Related]
19. Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa.
Meng D; Ragi SD; Tsang SH
Mol Ther; 2020 Oct; 28(10):2139-2149. PubMed ID: 32882181
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Mouse Models of Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation of Rhodopsin.
Barwick SR; Smith SB
Adv Exp Med Biol; 2023; 1415():341-345. PubMed ID: 37440054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
